Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Castel

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Medicina Cutanea Ibero-Latino-Americana|January 1, 1974
[Chronic light dermatitis, its relation with actinic reticuloid, the photosensitizing eczema and the persistent reactions to light]J Pinol Aguadé, M Lecha, T Estrach, et al.
Medicina Clinica|February 24, 1990
[Primary malignant melanoma of the skin. Retrospective study of 375 cases. Clinical aspects and histology]T Castel, M Baradad, J Castro, et al.
American Journal of Human Genetics|August 1, 1995
Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) geneS Puig, A Ruiz, C Lázaro, et al.
Anticancer Research|July 22, 2005
S-100beta and MIA in advanced melanoma in relation to prognostic factorsJ M Auge, R Molina, X Filella, et al.
Melanoma Research|July 13, 2000
Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of BarcelonaS Puig, J Castro, P J Ventura, et al.
Dermatologica|January 1, 1991
Adjuvant treatment in stage I and II malignant melanoma: a randomized trial between chemoimmunotherapy and immunotherapyT Castel, J Estapé, N Viñolas, et al.
Journal of Medical Genetics|June 30, 2000
CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasiaA Ruiz, S Puig, J Malvehy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosisB Mellado, D Colomer, T Castel, et al.
Anticancer Research|March 14, 2007
Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanomaM González Cao, J M Auge, R Molina, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2004
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysateR Vilella, D Benítez, J Milà, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Medicina Cutanea Ibero-Latino-Americana|January 1, 1974
[Chronic light dermatitis, its relation with actinic reticuloid, the photosensitizing eczema and the persistent reactions to light]J Pinol Aguadé, M Lecha, T Estrach, et al.
Medicina Clinica|February 24, 1990
[Primary malignant melanoma of the skin. Retrospective study of 375 cases. Clinical aspects and histology]T Castel, M Baradad, J Castro, et al.
American Journal of Human Genetics|August 1, 1995
Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) geneS Puig, A Ruiz, C Lázaro, et al.
Anticancer Research|July 22, 2005
S-100beta and MIA in advanced melanoma in relation to prognostic factorsJ M Auge, R Molina, X Filella, et al.
Melanoma Research|July 13, 2000
Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of BarcelonaS Puig, J Castro, P J Ventura, et al.
Dermatologica|January 1, 1991
Adjuvant treatment in stage I and II malignant melanoma: a randomized trial between chemoimmunotherapy and immunotherapyT Castel, J Estapé, N Viñolas, et al.
Journal of Medical Genetics|June 30, 2000
CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasiaA Ruiz, S Puig, J Malvehy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosisB Mellado, D Colomer, T Castel, et al.
Anticancer Research|March 14, 2007
Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanomaM González Cao, J M Auge, R Molina, et al.
Cancer Immunology, Immunotherapy : CII|March 5, 2004
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysateR Vilella, D Benítez, J Milà, et al.
Pageof 7